Mothers' willingness to pay for daughters' HPV vaccine in northern Vietnam

HPV vaccine is effective in preventing human papillomavirus, the main cause of cervical cancer. In Vietnam, at first, it was subsidized at $5 a dose and reached the coverage of 96% in two pilot provinces, indicating potentially high acceptance. Currently, it is provided at $120-195 for three doses....

Full description

Saved in:
Bibliographic Details
Published in:Health care for women international 2018-04, Vol.39 (4), p.450-462
Main Authors: Dinh Thu, Ha, Nguyen Thanh, Huong, Hua Thanh, Thuy, Nguyen Hai, Le, Tran Thi, Van, Nguyen Manh, Tri, Buvé, Anne
Format: Article
Language:English
Subjects:
Adolescent
Adult
Affordability
Attitudes
Cervical cancer
Childrens health
Choice Behavior
Cross-Sectional Studies
Daughters
Dosage
Female
Girls
Health care expenditures
Human papillomavirus
Humans
Middle Aged
Mothers
Mothers - psychology
Nuclear Family
Nursing
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines - administration & dosage
Papillomavirus Vaccines - economics
Patient Acceptance of Health Care
Provinces
Rural communities
Rural Population
Teenagers
Uterine Cervical Neoplasms - prevention & control
Vaccination - economics
Vaccines
Vietnam
Willingness to pay
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:HPV vaccine is effective in preventing human papillomavirus, the main cause of cervical cancer. In Vietnam, at first, it was subsidized at $5 a dose and reached the coverage of 96% in two pilot provinces, indicating potentially high acceptance. Currently, it is provided at $120-195 for three doses. This is a cross-sectional study, conducted in two northern rural districts of Vietnam. Researchers present findings to show 53.1% of mothers stated their willingness to pay (WTP) for HPV vaccine for their daughters. Perceptions on cost and condom use were associated with WTP. Mothers' affordability ranged from under $23 to $46. Measures should be implemented soon to make HPV vaccine more affordable.
ISSN:0739-9332
1096-4665
DOI:10.1080/07399332.2017.1411914